1601 TRAPELO ROAD, WALTHAM, MA
Amendments to Certificate of Incorporation Approved at 2026 Annual Meeting
Minerva Neurosciences Enters $75 Million Sales Agreement with Leerink Partners
Provides First Quarter 2026 Financial Results and Business Updates
Annual Report to Security Holders
Other Events
Announces Leadership Transition
Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Business Updates
Material disclosure
Q1
FY 2025
Q3
Q2
Amended Annual Report
FY 2023
Prospectus filed pursuant to Rule 424(b)(5)
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Prospectus filed pursuant to Rule 424(b)(3)
Registration Statement for Securities to be Offered to Employees
Definitive Proxy Statement
Additional Proxy Materials
PRE 14A
Amended Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Correspondence
Submission Upload